Search Results - "Kang, Keon Wook"

Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy.

Authors: Im, Ji Hye Kang, Keon Wook Kim, Sun Young et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 5/17/2022, Vol. 41 Issue 1, p1-1. 1p.

Radiation-induced exosomal miR-21 enhances tumor proliferation and invasiveness in breast cancer: implications for poor prognosis in radiotherapy patients.

Authors: Kim, Kyungmin Jung, Kyung Oh Oh, Sera et al.

Source: Experimental Hematology & Oncology. 12/18/2024, Vol. 13 Issue 1, p1-6. 6p.

Author Index.

Source: Journal of Labelled Compounds & Radiopharmaceuticals. May2017 Supplement, Vol. 60, p641-659. 19p.

Author Index.

Source: Journal of Labelled Compounds & Radiopharmaceuticals. May2015 Supplement, Vol. 58, pS412-S435. 24p.

First Real-World Evidence on the Safety and Effectiveness of Lutathera TM for Treating Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Insights from Post-Marketing Surveillance.

Authors: Kim, Yong-il Suh, Hoon Young Kang, Yehrim et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p2992. 14p.

Blood-based transcriptomic biomarkers for response to [¹⁷⁷Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors.

Authors: Sung, Hyunpil Bae, Sungwoo Suh, Minseok et al.

Source: EJNMMI Research. 8/2/2025, Vol. 15 Issue 1, p1-10. 10p.

International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.

Authors: Tian, Mei Zuo, Chuantao Cahid Civelek, A. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2024, Vol. 51 Issue 2, p434-442. 9p.

High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader.

Authors: Park, Jaewoo Joo, Min Sung Kim, Myung Jun et al.

Source: Experimental Hematology & Oncology. 6/23/2025, Vol. 14 Issue 1, p1-26. 26p.

International consensus on the use of [¹⁸F]-FDG PET/CT in pediatric patients affected by epilepsy.

Authors: Tian, Mei Watanabe, Yasuyoshi Kang, Keon Wook et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2021, Vol. 48 Issue 12, p3827-3834. 8p. 1 Diagram, 1 Chart, 1 Graph.

GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy.

Authors: Im, Ji Hye Kang, Keon Wook Kim, Sun Young et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 11/29/2018, Vol. 37 Issue 1, p1-15. 15p.

Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate‐decorated albumin nanoclusters in osteosarcoma treatment.

Authors: Yoo, So‐Yeol Mun, Yong‐Hyeon Kang, Nae‐Won et al.

Source: Bioengineering & Translational Medicine; Nov2023, Vol. 8 Issue 6, p1-14, 14p

Uncovering the impact of UV radiation on mitochondria in dermal cells: a STED nanoscopy study.

Authors: Kim, Hyung Jun Jin, Seon-Pil Kang, Jooyoun et al.

Source: Scientific Reports. 4/15/2024, Vol. 14 Issue 1, p1-9. 9p.

Design, Synthesis, and Biological Evaluation of 5′,7-Disubstituted 7-Deaza-adenosine Analogues as Irreversible Pan-FGFR Inhibitors.

Authors: Park, Jung Hoon Tran, Phuong Thao Ko, Hye Lin et al.

Source: Pharmaceuticals (14248247). Nov2025, Vol. 18 Issue 11, p1745. 43p.

From Genome to Phenome: Opportunities and Challenges of Molecular Imaging.

Authors: Tian, Mei Hood, Leroy Chiti, Arturo et al.

Source: Journal of Nuclear Medicine. Jun2025, Vol. 66 Issue 6, p851-855. 5p.

Evaluation of Fibroblast Activation Protein Expression Using ⁶⁸Ga-FAPI46 PET in Hypertension-Induced Tissue Changes.

Authors: Byun, Jung Woo Paeng, Jin Chul Kim, Young Ju et al.

Source: Journal of Nuclear Medicine. Nov2024, Vol. 65 Issue 11, p1776-1781. 6p.

Reliability and feasibility of visual grading systems and quantitative indexes on [^99mTc]Tc-DPD imaging for cardiac amyloidosis.

Authors: Bae, Sungwoo Gil, Joonhyung Paeng, Jin Chul et al.

Source: Scientific Reports. 10/14/2022, Vol. 12 Issue 1, p1-9. 9p.

CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine.

Authors: Kim, Hyun Young Baek, Ga Hee Lee, Wonseok et al.

Source: Clinical & Translational Medicine. May2022, Vol. 12 Issue 5, p1-7. 7p.

International consensus on the use of tau PET imaging agent ¹⁸F-flortaucipir in Alzheimer's disease.

Authors: Tian, Mei Civelek, A. Cahid Carrio, Ignasi et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2022, Vol. 49 Issue 3, p895-904. 10p. 1 Color Photograph, 1 Diagram.

FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization.

Authors: Suh, Hoon Young Choi, Hongyoon Cho, Sun Wook et al.

Source: Cancer Medicine. Aug2023, Vol. 12 Issue 16, p17068-17077. 10p.

Dickkopf-1 promotes tumor progression of gefitinib- resistant non-small cell lung cancer through cancer cell-fibroblast interactions.

Authors: Choi, Munkyung Choi, Yong June Lee, Young Joo et al.

Source: Experimental Hematology & Oncology. 3/1/2025, Vol. 14 Issue 1, p1-18. 18p.